Breast- Invasive breast cancer of no special type (NST) displaying a strong nuclear nucleolin immunostaining with a particularly strong staining in the nucleoli.

Breast- Invasive lobular breast cancer displaying a strong nuclear nucleolin positivity.

Colon- Colorectal adenocarcinoma showing strong nuclear immunostaining for nucleolin with a particularly strong intensity in nucleoli.

Esophagus- Adenocarcinoma with strong nuclear immunostaining for nucleolin with a particularly strong intensity in nucleoli.

Esophagus- Squamous cell carcinoma exhibiting a distinct nucleolar nucleolin immunostaining. Staining is markedly weaker in other areas of the nuclei.

Kidney- Clear cell renal cell carcinoma showing a strong nuclear nucleolin immunostaining.

Kidney- Oncocytoma showing a strong nuclear nucleolin immunostaining.

Kidney- Papillary renal cell carcinoma exhibiting a strong nuclear nucleolin positivity with a particularly strong staining intensity in the nucleoli.

Oral cavity- Squamous cell carcinoma showing strong nuclear immunostaining for nucleolin.

Ovary- Clear cell carcinoma showing a strong nuclear immunostaining for nucleolin.

Ovary- Endometroid carcinoma showing a moderate nuclear nucleolin immunostaining. Staining is particularly strong in nucleoli.

Ovary- Mucinous carcinoma showing a strong nuclear nucleolin immunostaining with a predominance of the staining in the nucleoli.

Ovary- Serous high-grade carcinoma displaying a strong nuclear nucleolin immunostaining.

Ovary- Serous high-grade carcinoma displaying an intense nuclear nucleolin immunostaining.

Pharynx- Squamous cell carcinoma showing nuclear nucleolin immunostaining with a particularly strong intensity in nucleoli.

Pharynx- Squamous cell carcinoma showing strong nuclear nucleolin immunostaining.

Prostate- Adenocarcinoma (Gleason 3+3=6) showing strong nuclear nucleolin immunostaining with a predominance of the staining in nucleoli.

Thyroid- Follicular carcinoma showing a moderate nuclear immunostaining for nucleolin with strong predominance of the staining in nucleoli.

Thyroid- Papillary carcinoma showing a moderate to strong nuclear nucleolin positivity.

Urinary bladder- Muscle-invasive urothelial carcinoma showing strong nuclear nucleolin positivity and a particularly strong staining intensity in nucleoli.

Urinary bladder- Non-invasive papillary urothelial carcinoma (pTa) showing a moderate to strong nucleolin immunostaining of nuclei.

Uterus – Endometroid endometrium carcinoma showing a heterogeneous pattern of nucleolin immunostaining. Cells with predominant cytoplasmic staining make up for the majority. They are intermingled with cells showing purely nuclear staining. Pattern may be biologically relevant or represent an artifact.

Uterus- Endometroid endometrium carcinoma with strong nuclear nucleolin staining.

Uterus- Serous endometrium carcinoma showing a strong nuclear nucleolin positivity with a particularly strong staining intensity in nucleoli.

Uterus, cervix – Adenocarcinoma showing a heterogeneous nucleolin immunostaining pattern. Cells with purely nuclear staining are intermingled with cells showing little nuclear but predominant cytoplasmic staining. Pattern may be biologically relevant or represent an artifact.

Uterus, cervix – Adenocarcinoma showing a heterogeneous pattern for nucleolin immunostaining. Cells with purely nuclear staining are intermingled with cells showing little nuclear but predominant cytoplasmic staining. Pattern may be biologically relevant or represent an artifact.

Uterus, cervix- Squamous cell carcinoma showing a strong nuclear positivity for nucleolin.

Vulva- Squamous cell carcinoma showing strong nuclear nucleolin positivity with a particularly strong staining intensity in the nucleoli.